- Advertise
- Contact Editorial
- Editorial Submission Guidelines
- Contact MJH Life Sciences
- Do Not Sell My Personal Information
- Privacy Policy
- Terms and Conditions
© 2023 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
Pharmaceutical Executive-06-01-2021
Three Ways to Overcome Any Market Challenge
June 09, 2021
Back Page
41
6
Pandemic-reinforced principles of successful drug launch.
Staying the Course: Double Down on Launch Agility
June 09, 2021
Features
41
6
In today’s fragmented commercial environment, navigating a more complex set of challenges while adapting new approaches to product launch is critical for biopharma brand teams.
Betting on Its Base in Virology
June 09, 2021
Features
41
6
How Gilead readied remdesivir for the COVID challenge.
Scientific Rigor, Urgent Action
June 09, 2021
Features
41
6
Inside Regeneron’s monoclonal antibody development to treat COVID.
Meeting the Crisis Head-On
June 09, 2021
Features
41
6
Past lessons, strong resolve, and complex coordination propel J&J’s vaccine efforts.
Innovation in High Gear
June 09, 2021
Features
41
6
Thrust into a commercial-stage company in just months, Moderna moves full steam ahead.
Bonds Old and New to the Rescue
June 09, 2021
Features
41
6
College roommates, industry partnerships help bring Pfizer vaccine to fruition.
2021 Pharm Exec Top 50 Companies
June 09, 2021
Features
41
6
Pharm Exec’s latest listing of the top global biopharma sales producers captures the critical business and public health balancing act that was required in the Year of COVID—reinforcing the staying power of building brand value while championing medical innovation.
After Blowout 2020, Biotech Worst Performing Sector YTD
June 09, 2021
Finance
41
6
What are the reasons behind the slump and what does the future hold?
A Steward of Science
June 09, 2021
Executive Profile
41
6
Building on a lifelong passion for biomedical research, and then its application in policy and health equity as a leader in various interconnected settings, Michelle McMurry-Heath, president and CEO of BIO, is uniquely positioned as a “translator” for science and social advocacy—and speaking stakeholders to action.
Product Analogs Point to Pricing and Distinct Payer Market Scenarios
June 09, 2021
Managed Markets
41
6
A business framework for pricing and broader brand strategy.
A Step Closer to 3D Printing for Personalized Medicines
June 09, 2021
Technology
41
6
How the UK is making progress in this hi-tech field.
A Management Blueprint for Return to ‘Normal’
June 09, 2021
Leadership
41
6
Leading in a post-quarantine world requires compassion and connection amid employees’ shifting situations.
Bringing a European Focus to Drug Import Vulnerabilities
June 09, 2021
Global Report
41
6
Pandemic triggers urgency around supply chain initiatives.
Pharma Prices and Patents Under Attack
June 09, 2021
Washington Report
41
6
Separate pushes for vaccine equity, legislation to lower drug costs.
Science is Underrated
June 09, 2021
From the Editor
41
6
Combined powers of synbio and biopharma point to bright future for industry.
A Strong Healthcare Ecosystem
June 09, 2021
Chairman’s Letter
41
6
A letter on the June 2021 issue of Pharm Exec from Chairman and Founder of MJH Life Sciences, Mike Hennessy Sr.
Pharmaceutical Executive, June 2021 Issue (PDF)
June 09, 2021
Issue PDF
41
6
Click the title above for a link to open the Pharmaceutical Executive June 2021 issue in an interactive PDF format.